Phase II Trial of Weekly Docetaxel, Vinorelbine, and Trastuzumab in the First-Line Treatment of Patients with HER2-Positive Metastatic Breast Cancer
Infante, Jeffrey R, Yardley, Denise A, Burris, Howard A, Greco, F. Anthony, Farley, Cindy P, Webb, Charles, Spigel, David R, Hainsworth, John D
Published in Clinical breast cancer (01.02.2009)
Published in Clinical breast cancer (01.02.2009)
Get full text
Journal Article
A Phase II Feasibility Trial of Dose-Dense Docetaxel Followed by Doxorubicin/Cyclophosphamide as Adjuvant or Neoadjuvant Treatment for Women with Node-Positive or High-Risk Node-Negative Breast Cancer
Yardley, Denise A, Burris, Howard A, Farley, Cindy P, Barton, John H, Peacock, Nancy W, Spigel, David R, Greco, F. Anthony, Hainsworth, John D
Published in Clinical breast cancer (01.06.2008)
Published in Clinical breast cancer (01.06.2008)
Get full text
Journal Article